Although no significant differences were observed, there is a clear trend towards more IL-32β and IL-32γ mRNA expression in the RA patients compared to the healthy individuals (Fig. 1A,B ).
← all excerpts
Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients.
1
—
—